Adaptive Biotechnologies Corp (ADPT)
3.01
+0.08
(+2.73%)
USD |
NASDAQ |
May 03, 16:00
3.005
0.00 (0.00%)
After-Hours: 20:00
Adaptive Biotechnologies Profit Margin (Quarterly): -151.7% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -151.7% |
| September 30, 2023 | -132.7% |
| June 30, 2023 | -97.72% |
| March 31, 2023 | -153.3% |
| December 31, 2022 | -72.70% |
| September 30, 2022 | -94.67% |
| June 30, 2022 | -119.2% |
| March 31, 2022 | -162.6% |
| December 31, 2021 | -162.0% |
| September 30, 2021 | -141.6% |
| June 30, 2021 | -128.0% |
| March 31, 2021 | -105.7% |
| Date | Value |
|---|---|
| December 31, 2020 | -147.7% |
| September 30, 2020 | -139.6% |
| June 30, 2020 | -159.8% |
| March 31, 2020 | -150.2% |
| December 31, 2019 | -85.14% |
| September 30, 2019 | -53.53% |
| June 30, 2019 | -70.73% |
| March 31, 2019 | -145.2% |
| December 31, 2018 | -77.19% |
| September 30, 2018 | -48.24% |
| June 30, 2018 | -108.0% |
| March 31, 2018 | -127.5% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-162.6%
Minimum
Mar 2022
-53.53%
Maximum
Sep 2019
-122.6%
Average
-132.7%
Median
Sep 2023
Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -110.2% |
| Palatin Technologies Inc | -385.6% |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -57.64% |
| Return on Assets | -29.71% |
| Return on Invested Capital | -57.64% |
| Gross Profit Margin (Quarterly) | 57.16% |
| Operating Margin (Quarterly) | -99.68% |
| Return on Net Operating Assets | -68.39% |